A Levitzki

发表

Platelet-derived Growth Factor Requires Epidermal Growth Factor Receptor to Activate p21-activated Kinase Family Kinases*

A. Levitzki, F. Walker, Hong-Jian Zhu, 2001, The Journal of Biological Chemistry.

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

A. Levitzki, A. Gazit, C. Gilon, 1988, Science.

Dimerization of Ste5, a mitogen-activated protein kinase cascade scaffold protein, is required for signal transduction.

A. Levitzki, D. Yablonski, A Levitzki, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Negative cooperativity in regulatory enzymes.

D E Koshland, D. Koshland, A. Levitzki, 1969, Proceedings of the National Academy of Sciences of the United States of America.

Tyrosine kinase inhibition: an approach to drug development.

A. Levitzki, A. Gazit, A Levitzki, 1995, Science.

The N-terminal half of Cdc25 is essential for processing glucose signaling in Saccharomyces cerevisiae.

A. Levitzki, A Levitzki, I. Marbach, 1999, Biochemistry.

A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.

V Hombach, V. Hombach, A. Levitzki, 1999, Circulation research.

Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.

A. Levitzki, A. Gazit, C. Gilon, 1991, Journal of medicinal chemistry.

Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.

A. Levitzki, A. Gazit, C. Gilon, 1993, The Journal of biological chemistry.

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

A. Levitzki, A. Gazit, C. Gilon, 1989, Journal of medicinal chemistry.

Signal-transduction therapy. A novel approach to disease management.

A. Levitzki, A Levitzki, 1994, European journal of biochemistry.

Stereospecific binding of propranolol and catecholamines to the beta-adrenergic receptor.

A. Levitzki, D. Atlas, M. Steer, 1974, Proceedings of the National Academy of Sciences of the United States of America.